The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Traditional Chinese Medicine in Cancer Care: A Review of Controlled Clinical Studies Published in Chinese
Open accessAbstract
BACKGROUND: Traditional Chinese medicine (TCM) has been widely applied for cancer care in China. There have been a large number of controlled clinical studies published in Chinese literature, yet no systematic searching and analysis has been done. This study summarizes the current evidence of controlled clinical studies of TCM for cancer. METHODS: We searched all the controlled clinical studies of TCM therapies for all kinds of cancers published in Chinese in four main Chinese electronic databases from their inception to November 2011. We bibliometrically analyzed the included studies and assessed the reporting quality. RESULTS: A total of 2964 reports (involving 253,434 cancer patients) including 2385 randomized controlled trials and 579 non-randomized controlled studies were included. The top seven cancer types treated were lung cancer, liver cancer, stomach cancer, breast cancer, esophagus cancer, colorectal cancer and nasopharyngeal cancer by both study numbers and case numbers. The majority of studies (72%) applied TCM therapy combined with conventional treatment, whilst fewer (28%) applied only TCM therapy in the experimental groups. Herbal medicine was the most frequently applied TCM therapy (2677 studies, 90.32%). The most frequently reported outcome was clinical symptom improvement (1667 studies, 56.24%) followed by biomarker indices (1270 studies, 42.85%), quality of life (1129 studies, 38.09%), chemo/radiotherapy induced side effects (1094 studies, 36.91%), tumor size (869 studies, 29.32%) and safety (547 studies, 18.45%). Completeness and adequacy of reporting appeared to improve with time. CONCLUSIONS: Data from controlled clinical studies of TCM therapies in cancer treatment is substantial, and different therapies are applied either as monotherapy or in combination with conventional medicine. Reporting of controlled clinical studies should be improved based on the CONSORT and TREND Statements in future. Further studies should address the most frequently used TCM therapy for common cancers and outcome measures should address survival, relapse/metastasis and quality of life.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Herbal medicines for advanced colorectal cancer
Guo, Z., Jia, X., Liu, J., Liao, J., & Yang, Y. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004653.pub2 · Cited by 27
Self-citationRetractedJemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
the CONSORT Group, Schulz, K. F., Altman, D. G., & Moher, D. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-18 · Cited by 13,371
Pharmacological interventions for somatoform disorders in adults
Kleinstäuber, M., Witthöft, M., Steffanowski, A., van Marwijk, H., Hiller, W., & Lambert, M. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010628.pub2 · Cited by 11,335
Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1. The Cochrane Collaboration
Higgins, J. P. T., Green, S. R., & Higgins, J. P. T. (2008) · Cited by 7,175
CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials
Schulz, K. F., Altman, D. G., Moher, D., & for the CONSORT Group* (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-11-201006010-00232 · Cited by 3,824
Ezzati, M., López, A. D., Rodgers, A., & Murray, C. J. L. (2004) · Cited by 3,319
Des Jarlais, D. C., Lyles, C., Crepaz, N., & the TREND Group (2004) · American Journal of Public Health · doi:10.2105/ajph.94.3.361 · Cited by 2,817
Danhier, F., Feron, O., & Préat, V. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.08.027 · Cited by 2,800
CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials
Schulz, K. F., Altman, D. G., Moher, D., & for the CONSORT Group (2010) · PLoS Medicine · doi:10.1371/journal.pmed.1000251 · Cited by 2,296
Boon, H. S., Olatunde, F., & Zick, S. M. (2007) · BMC Women's Health · doi:10.1186/1472-6874-7-4 · Cited by 379
Chinese medical herbs for chemotherapy side effects in colorectal cancer patients
Wu, T., Munro, A. J., Guanjian, L., & Liu, G. J. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004540.pub2 · Cited by 140
Jiang, M., Yang, J., Zhang, C., Liu, B., Chan, K., Cao, H., & Lü, A. (2010) · Planta Medica · doi:10.1055/s-0030-1250456 · Cited by 118
Self-citationChinese medicinal herbs to treat the side-effects of chemotherapy in breast cancer patients
Zhang, M., Liu, X., Li, J., He, L., & Tripathy, D. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004921.pub2 · Cited by 108
Yang, G., Li, X., Li, X., Wang, L., Li, J., Song, X., Chen, J., Guo, Y., Sun, X., Wang, S., et al. (2012) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/751046 · Cited by 76
Self-citationUse of Chinese medicine by cancer patients: a review of surveys
Carmady, B., & Smith, C. A. (2011) · Chinese Medicine · doi:10.1186/1749-8546-6-22 · Cited by 60
Liu, J., Li, X., Liu, J., Ma, L., Li, X., & Fønnebø, V. M. (2011) · Forschende Komplementärmedizin / Research in Complementary Medicine · doi:10.1159/000333065 · Cited by 42
Self-citationShuai, G., He, T., & Hu, H. (2014) · Chinese Medicine · doi:10.1186/1749-8546-9-22 · Cited by 24
Let's talk 'cancer prevention'.
Yoder, L. H. (2005) · PubMed · Cited by 10
Cited by
The amazing potential of fungi: 50 ways we can exploit fungi industrially
Hyde, K. D., Xu, J., Rapior, S., Jeewon, R., Lumyong, S., Niego, A. G. T., Abeywickrama, P. D., Aluthmuhandiram, J. V. S., Brahamanage, R. S., Brooks, S., et al. (2019) · Fungal Diversity · doi:10.1007/s13225-019-00430-9 · Cited by 811
Self-citationRushworth, G. F., & Megson, I. L. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.09.006 · Cited by 719
Link prediction techniques, applications, and performance: A survey
Kumar, A., Singh, S. S., Singh, K., & Biswas, B. (2020) · Physica A: Statistical Mechanics and its Applications · doi:10.1016/j.physa.2020.124289 · Cited by 516
Challenges to effective cancer control in China, India, and Russia
Goss, P. E., Strasser-Weippl, K., Lee-Bychkovsky, B. L., Fan, L., Li, J., Chavarri-Guerra, Y., Liedke, P. E. R., Pramesh, C. S., Badovinac-Crnjevic, T., Sheikine, Y., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70029-4 · Cited by 496
Qi, F., Zhao, L., Zhou, A., Zhang, B., Li, A., Wang, Z., & Han, J. (2015) · BioScience Trends · doi:10.5582/bst.2015.01019 · Cited by 481
Metadata
- Authors
- Li, X., Yang, G., Li, X., Zhang, Y., Yang, J., Chang, J., Sun, X., Zhou, X., Guo, Y., Xu, Y., Liu, J., & Bensoussan, A.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-04-03
- Volume
- 8
- Issue
- 4
- Pages
- e60338
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2077293849
- Cited by
- 603
- References
- 19
- FWCI
- 158.05
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.